Your session is about to expire
← Back to Search
Deep Brain Stimulation for Alcoholism
Study Summary
This trial will test if brain stimulation can help treat Alcohol Use Disorder in people who have not responded to other treatments. It will measure the safety and effectiveness of the treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 53 Patients • NCT01221948Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the proposed outcomes of this clinical trial?
"This medical trial will monitor patients' safety and tolerance for approximately 6 months, recording their adverse events. Secondary objectives involve comparing the Beck Depression and Anxiety Inventory (BDI/BAI), Alcohol Use Disorder Identification Test (AUDIT) and Alcohol Dependency Scale (ADS) between preoperative baseline measurements taken at the start of the study to those taken after a 6-month period."
Does this research embrace individuals of varying ages, including those over 45 years old?
"Eligibility for this clinical trial is limited to individuals aged 18-70. There are 35 studies available to those under the age of majority and 265 specifically targeting seniors above 65 years old."
Is recruitment for this clinical experiment currently available?
"Per the information provided on clinicaltrials.gov, this medical trial is not actively enrolling patients at present time. It was initially posted in May of 2018 and last updated in September 2020; however, 383 other trials are presently seeking participants."
Is there any way I can become a participant in this clinical investigation?
"For this medical investigation, 10 participants with a diagnosed alcohol use disorder aged 18-70 are being enrolled. To be eligible for the trial, patients must have an AUDIT Scale Score >8 and evidence of multiple attempts to treat their condition using conventional therapies (psychosocial treatments plus disulfiram, naltrexone or acamprosate). Additionally, they must agree to sign informed consent documents and adhere strictly to study protocol."
Share this study with friends
Copy Link
Messenger